Glenmede Trust’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Glenmede Trust’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	–	–	3315
2018 Q4	$0	Buy	+4	New	+$4	﹤0.01%	3179
2017 Q4	–	Sell	-4	Closed	–	–	2938
2017 Q3	$0	Hold	4	–	–	﹤0.01%	3002
2017 Q2	$0	Hold	4	–	–	﹤0.01%	2762
2017 Q1	$0	Hold	4	–	–	﹤0.01%	2873
2016 Q4	$0	Hold	4	–	–	﹤0.01%	2782
2016 Q3	$0	Hold	4	–	–	﹤0.01%	2812
2016 Q2	$0	Hold	4	–	–	﹤0.01%	2907
2016 Q1	$0	Hold	4	–	–	﹤0.01%	2865
2015 Q4	$0	Hold	4	–	–	﹤0.01%	2945
2015 Q3	$0	Hold	4	–	–	﹤0.01%	3010
2015 Q2	$0	Buy	+4	New	+$38	﹤0.01%	2933

Glenmede Trust's AST Position: Q1 2019 in Review

Glenmede Trust sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 4 shares.

Glenmede Trust first reported a position in AST in Q2 2015 and held it in 11 quarters. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Glenmede Trust reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Glenmede Trust sold 4 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
Glenmede Trust first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 11 quarters.
Glenmede Trust's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.